ABM is looking for a limited, temporary contract position for a period of 1-2 years for a recent PhD graduate in Cognitive Psychology, Cognitive Neuroscience, or Cognitive Sciences. The initial contract will be limited to one year, with a potential extension for a second year based on performance and workload/funding.

Job requirements:
1) Data Analysis, preferably experience with SPSS, with SAS and MATLAB experience being desirable. Must be able to accomplish basic statistical analysis, and be able to identify trends and interesting patterns in the data. Minimum analytical techniques: ANOVA, RMANOVA, correlations, non-parametrics. Highly desirable: Multivariate techniques, Regression, Factor analysis.

2) Excellent writing skills, as the primary goal for this position for ABM is to have the candidate write at least 4-6 papers based on our database of over 2000 neurocognitive test sessions, that includes healthy (rested and sleep deprived) and sleep disordered subjects of all ages from multiple studies.

3) Contribute to design of final neurocognitive testing tool and database, including potential to write grant(s) to fund final development.

4) EEG background is highly desirable


Required Skills:
1) Microsoft Office skill must be excellent and intermediate or above
2) SPSS/SAS skills
3) Background in EEG, Neuropsychological and/or Neurocognitive testing
4) Writing skills


Compensation will include: $40-50K based on experience, health and dental insurance, and 2 weeks paid vacation per year.
Earliest start date will be October 1, 2009, but may be delayed based on quality of respondents
If you are interested in this position, please submit your CV and a writing sample to: HR@b-alert.com
For more information on ABM please go to www.b-alert.com/

Advanced Brain Monitoring, Inc. (ABM) develops and delivers innovative solutions for sleep apnea diagnosis, memory dysfunction measurement and alertness monitoring. ABM helps clinicians provide better patient care at lower cost with products that combine laboratory level accuracy with the portability, ease of use and affordability of micro-electronics. ABM received over $7 million in grants from the National Institutes of Health and the Department of Defense to develop and validate its innovative technologies.

ABM’s pioneering and practical suite of assessment tools identify the presence and severity of obstructive sleep apnea (OSA) and quantify the daytime consequences of OSA including drowsiness and memory loss. The comprehensive data and interpretive reports can be used to select the optimal treatment and to evaluate the effectiveness of treatment. ABM first targeted the highly prevalent, under-diagnosed OSA, but its systems have applications to a wide range of diseases including Alzheimer’s, head trauma, stroke, and other sleep and neurological disorders. Alertness monitoring also has clear applications in safety-sensitive occupations such as the transportation industry.

ABM is a privately held corporation based in Carlsbad, California with offices in Belgrade, Serbia and Montenegro.